PASSARIELLO, MARGHERITA
 Distribuzione geografica
Continente #
AS - Asia 1.722
NA - Nord America 1.340
EU - Europa 1.217
SA - Sud America 206
Continente sconosciuto - Info sul continente non disponibili 83
AF - Africa 47
OC - Oceania 1
Totale 4.616
Nazione #
US - Stati Uniti d'America 1.274
SG - Singapore 658
RU - Federazione Russa 537
IT - Italia 376
CN - Cina 364
VN - Vietnam 346
BR - Brasile 153
HK - Hong Kong 145
DE - Germania 74
FR - Francia 60
NL - Olanda 53
IN - India 47
JP - Giappone 35
BD - Bangladesh 33
CA - Canada 33
GB - Regno Unito 29
KR - Corea 25
MX - Messico 22
FI - Finlandia 16
ZA - Sudafrica 16
CI - Costa d'Avorio 15
EC - Ecuador 15
AT - Austria 12
IQ - Iraq 12
PL - Polonia 12
AR - Argentina 11
ID - Indonesia 9
PH - Filippine 9
PY - Paraguay 9
SE - Svezia 9
ES - Italia 7
IE - Irlanda 5
PK - Pakistan 5
TR - Turchia 5
BE - Belgio 4
CL - Cile 4
CO - Colombia 4
LT - Lituania 4
MA - Marocco 4
SA - Arabia Saudita 4
VE - Venezuela 4
CH - Svizzera 3
MY - Malesia 3
PE - Perù 3
RO - Romania 3
TH - Thailandia 3
UA - Ucraina 3
EG - Egitto 2
ET - Etiopia 2
GT - Guatemala 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LV - Lettonia 2
PA - Panama 2
TW - Taiwan 2
UY - Uruguay 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
LC - Santa Lucia 1
LY - Libia 1
MD - Moldavia 1
MU - Mauritius 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
RS - Serbia 1
SN - Senegal 1
SV - El Salvador 1
TN - Tunisia 1
Totale 4.533
Città #
Singapore 326
San Jose 282
Naples 164
Hong Kong 143
Moscow 141
Ashburn 133
Beijing 115
Ho Chi Minh City 100
Hefei 94
Chandler 78
Santa Clara 74
Hanoi 60
Los Angeles 53
Amsterdam 49
The Dalles 44
Lauterbourg 33
New York 33
Tokyo 27
Napoli 24
São Paulo 24
Dallas 23
Munich 22
Boston 20
Pune 18
Rome 18
Seoul 18
Lawrence 17
Haiphong 16
Buffalo 14
Ercolano 14
Seattle 14
Redondo Beach 13
Da Nang 12
Frankfurt am Main 12
Orem 11
Atlanta 10
Capaccio 10
Des Moines 10
Kochi 10
Millbury 10
Shanghai 10
Brooklyn 9
Falkenstein 9
Helsinki 9
Milan 9
Warsaw 9
Biên Hòa 8
Council Bluffs 8
Denver 8
Düsseldorf 8
Houston 8
Hải Dương 8
Nuremberg 8
Toronto 8
Wilmington 8
Chicago 7
London 7
Mexico City 7
Quito 7
Thái Bình 7
Acerra 6
Columbus 6
Montreal 6
Johannesburg 5
Vienna 5
Bologna 4
Brussels 4
Can Tho 4
Cape Town 4
Chennai 4
Guangzhou 4
Lappeenranta 4
Marano di Napoli 4
Nanjing 4
New Delhi 4
Ninh Bình 4
Phoenix 4
Poplar 4
Portsmouth 4
Salvador 4
Stockholm 4
Baghdad 3
Bexley 3
Bắc Giang 3
Calgary 3
Campinas 3
Casavatore 3
Caserta 3
Ciudad del Este 3
Erbil 3
Guayaquil 3
Kuala Lumpur 3
Long Xuyen 3
Nha Trang 3
Pozzuoli 3
Queens 3
Quảng Ngãi 3
Rio de Janeiro 3
San Francisco 3
Shijiazhuang 3
Totale 2.600
Nome #
A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab 180
Oncolytic Adenoviral Vector-Mediated Expression of an Anti-PD-L1-scFv Improves Anti-Tumoral Efficacy in a Melanoma Mouse Model 176
Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics 176
Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2 173
Long-chain polyphosphates impair SARS-CoV-2 infection and replication 171
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer 160
Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanoma 155
Combinatorial immune checkpoint blockade increases myocardial expression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemical implications in cardio-immuno-oncology 151
Rapid Affinity Maturation of Novel Anti-PD-L1 Antibodies by a Fast Drop of the Antigen Concentration and FACS Selection of Yeast Libraries 149
Massive parallel screening of phage libraries for the generation of repertoires of human immunomodulatory monoclonal antibodies. 148
Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK Cells 147
A long non-coding SINEUP RNA boosts semi-stable production of fully human monoclonal antibodies in HEK293E cells 146
Novel Human Bispecific Aptamer-Antibody Conjugates for Efficient Cancer Cell Killing 140
Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling 138
Evaluation of the antiproliferative effect of Bifidobacterium longum BB-536 in solid tumor cell lines, co-cultured with murine splenocytes 138
Novel combinations of human immunomodulatory mAbs lacking cardiotoxic effects for therapy of TNBC 136
New Insights on the Role of Anti-PD-L1 and Anti-CTLA-4 mAbs on Different Lymphocytes Subpopulations in TNBC 134
Interactions of spike‐rbd of sars‐cov‐2 and platelet factor 4: New insights in the etiopathogenesis of thrombosis 134
High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand 134
Immunomodulatory mabs as tools to investigate on cis-interaction of pd-1/pd-l1 on tumor cells and to set up methods for early screening of safe and potent combinatorial treatments 132
Fusion proteins 128
Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays 126
Novel Bi-Specific Immuno-Modulatory Tribodies Potentiate T Cell Activation and Increase Anti-Tumor Efficacy 124
T-cell Activating Tribodies as a Novel Approach for Efficient Killing of ErbB2-positive Cancer Cells. 124
Novel tri-specific tribodies induce strong T cell activation and anti-tumor effects in vitro and in vivo 123
Ipilimumab and Its Derived EGFR Aptamer-Based Conjugate Induce Efficient NK Cell Activation against Cancer Cells. 121
Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways 117
HUMAN ANTI-FV ANTIBODY, THERAPEUTIC AND DIAGNOSTIC APPLICATIONS THEREOF 116
A Comparison of the Antitumor Efficacy of Novel Multi-Specific Tribodies with Combinations of Approved Immunomodulatory Antibodies 114
Evidences of CTLA-4 and PD-1 blocking agents-induced cardiotoxicity in cellular and preclinical models 108
Superior Suppression of ErbB2-positive Tumor Cells by a Novel Human Triparatopic Tribody 107
A Novel Human Anti-FV mAb as a Potential Tool for Diagnostic and Coagulation Inhibitory Approaches 94
Cardiotoxicity and pro-inflammatory effects of the immune checkpoint inhibitor Pembrolizumab associated to Trastuzumab 87
Generation of novel human anti-OX-40 mAbs endowed with different biological properties as tools for cancer therapy 83
Evidence of Cardiotoxic Immune Activation by Triple Immune Checkpoint Blockade: A Translational Alert for Clinical Surveillance in Patients With Cancer 26
Totale 4.616
Categoria #
all - tutte 14.230
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.230


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022145 0 4 1 1 1 4 16 9 10 21 41 37
2022/2023241 19 12 9 13 29 25 0 24 37 46 23 4
2023/2024234 10 28 52 21 9 39 10 25 0 2 23 15
2024/20251.273 48 33 23 32 32 111 112 76 66 153 508 79
2025/20262.556 267 198 253 212 397 118 333 104 327 180 106 61
2026/202758 45 13 0 0 0 0 0 0 0 0 0 0
Totale 4.616